| Absorption |
| Blood-Brain Barrier | BBB- | 0.9510 |
| Human Intestinal Absorption | HIA+ | 0.9910 |
| Caco-2 Permeability | Caco2- | 0.8957 |
| P-glycoprotein Substrate | Substrate | 0.5665 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9348 |
| Non-inhibitor | 0.9756 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8917 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6451 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7750 |
| CYP450 2D6 Substrate | Non-substrate | 0.7495 |
| CYP450 3A4 Substrate | Non-substrate | 0.7040 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9371 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9190 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8943 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9496 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9169 |
| Non-inhibitor | 0.9269 |
| AMES Toxicity | Non AMES toxic | 0.9226 |
| Carcinogens | Non-carcinogens | 0.8864 |
| Fish Toxicity | High FHMT | 0.7252 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8700 |
| Honey Bee Toxicity | High HBT | 0.5443 |
| Biodegradation | Not ready biodegradable | 0.8428 |
| Acute Oral Toxicity | III | 0.8218 |
| Carcinogenicity (Three-class) | Non-required | 0.5861 |